Re: Purified protein derivative skin test reactions are associated with clinical outcomes of patients with nonmuscle invasive bladder cancer treated with induction Bacillus Calmette-Guerin therapy

被引：1
|
作者：
Krajewski, Wojciech [1 ]
Zdrojowy, Romuald [1 ]
Kolodziej, Anna [1 ]
机构：
[1] Wroclaw Med Univ, Dept Urol & Oncol Urol, Wroclaw, Poland
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2019年 / 37卷 / 06期
关键词：
Nonmuscle-invasive bladder cancer; Bacillus Calmette-Guerin; Recurrence; Progression; Purified protein derivative skin test;
D O I：
10.1016/j.urolonc.2019.01.024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：346 / 347
页数：2
相关论文
共 50 条
  • [41] Re: Diminished Efficacy of Bacille Calmette-Guerin Among Elderly Patients With Nonmuscle Invasive Bladder Cancer Editorial Comment
    Griebling, Tomas L.
    JOURNAL OF UROLOGY, 2012, 187 (03): : 879 - 880
  • [42] Editorial comment on "Maintenance bacillus Calmette-Guerin therapy for nonmuscle-invasive bladder cancer: A need for more randomized trials"
    Huang, Shu-Pin
    UROLOGICAL SCIENCE, 2015, 26 (02) : 101 - +
  • [43] Association of Polymorphisms in Oxidative Stress Genes with Clinical Outcomes for Bladder Cancer Treated with Bacillus Calmette-Guerin
    Wei, Hua
    Kamat, Ashish
    Chen, Meng
    Ke, Hung-Lung
    Chang, David W.
    Yin, Jikai
    Grossman, H. Barton
    Dinney, Colin P.
    Wu, Xifeng
    PLOS ONE, 2012, 7 (06):
  • [44] Intravesical Bacillus Calmette-Guerin Outcomes in Patients With Bladder Cancer and Asymptomatic Bacteriuria
    Herr, Harry W.
    JOURNAL OF UROLOGY, 2012, 187 (02): : 435 - 437
  • [45] Impact of UTUC on Outcomes of Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guerin
    Bree, K. K.
    Hensley, P. J.
    Brooks, N.
    Matulay, J.
    Navai, N.
    Grossman, H. B.
    Matin, S. F.
    Dinney, C. P.
    Kamat, A. M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (12) : 898 - 898
  • [46] The Challenge of Bacillus Calmette-Guerin Failure in Nonmuscle Invasive Bladder Cancer-What is the Next Step in Management?
    Lotan, Yair
    JOURNAL OF UROLOGY, 2013, 190 (03): : 832 - 833
  • [47] Cost-Effectiveness of Maintenance bacillus Calmette-Guerin for Intermediate and High Risk Nonmuscle Invasive Bladder Cancer
    Sharma, Vidit
    Wymer, Kevin M.
    Borah, Bijan J.
    Saigal, Christopher S.
    Litwin, Mark S.
    Packiam, Vignesh T.
    Thompson, R. Houston
    Tollefson, Matthew K.
    Karnes, R. Jeffrey
    Boorjian, Stephen A.
    JOURNAL OF UROLOGY, 2020, 204 (03): : 442 - 449
  • [48] Intravesical Gemcitabine for High Risk, Nonmuscle Invasive Bladder Cancer after Bacillus Calmette-Guerin Treatment Failure
    Sternberg, Itay A.
    Dalbagni, Guido
    Chen, Ling Y.
    Donat, Sherri M.
    Bochner, Bernard H.
    Herr, Harry W.
    JOURNAL OF UROLOGY, 2013, 190 (05): : 1686 - 1691
  • [49] Association between Metabolic Syndrome and Recurrence of Nonmuscle Invasive Bladder Cancer following bacillus Calmette-Guerin Treatment
    Lenis, Andrew T.
    Asanad, Kian
    Blaibel, Maher
    Donin, Nicholas M.
    Chamie, Karim
    UROLOGY PRACTICE, 2018, 5 (02) : 132 - 137
  • [50] Clinical outcomes of bacillus Calmette-Guerin instillation therapy for carcinoma in situ of urinary bladder
    Takenaka, Atsushi
    Yamada, Yuji
    Miyake, Hideaki
    Hara, Isao
    Fujisawa, Masato
    INTERNATIONAL JOURNAL OF UROLOGY, 2008, 15 (04) : 309 - 313
12345